Bionow | News

The Latest Industry News

Access and download our newsletters from the Newsletter Archive

As well as keeping you up to date with the latest developments within the life sciences sector, Bionow members can also post updates to the Bionow News page to promote themselves to over 300 Bionow member organisations and the UK Life Sciences sector.

Whether currently a member or not, keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

A to Z: Drugs in Highlight: C is for CERDELGA

Dec 5th 2024

Join us on this educational journey through the alphabet of pharmaceutical drugs. Whether you’re a healthcare professional, a student, or simply someone with a curious mind, “A to Z: Dru...

A to Z: Drugs in Highlight: A is for AKEEGA®

Nov 19th 2024

Join us on this educational journey through the alphabet of pharmaceutical drugs. Whether you’re a healthcare professional, a student, or simply someone with a curious mind, “A to Z: Dru...

Morning Sickness: The Role of Drug Repurposing and Intellectual Property Conside...

Sep 18th 2024

Recent breakthroughs in understanding the underlying causes of morning sickness offer exciting opportunities for drug repurposing. Our latest article explores how researchers can leverage ex...

University launches new biotech spin-out company

Jun 28th 2024

The University of Liverpool has launched a new biotech spin-out company to develop novel therapeutic drugs for the treatment of cancer and fibrotic diseases.

AstraZeneca, on fast track of growth, sets revenue target at $80B by 2030

May 22nd 2024

In his first decade as CEO at AstraZeneca, Pascal Soriot achieved one ambitious revenue goal. Now he shoots for another, targeting sales of $80 billion for the drugmaker by 2030.

A cure for resistance? How ultra-long patent terms may entice pharma to address...

Jan 6th 2023

Addressing the antimicrobial resistance crisis will require a multifaceted approach - could extending patent terms encourage pharmaceutical companies to drive innovation in this area? Potte...

Innovative COVID-19 drug testing platform launched

Jul 9th 2020

The University of Liverpool, Liverpool School of Tropical Medicine and Southampton Clinical Trials Unit have announced the launch of an innovative COVID-19 drug testing platform, AGILE.

Liverpool ChiroChem secures £2.25m investment

May 4th 2020

Liverpool ChiroChem has secured £2.25m in a funding round led by the VC firms Deepbridge Capital and Praetura Ventures.

Corona Virus (COVID-19) Therapeutics: £10 Million Call for Rapid Deployment

Mar 20th 2020

Funding available for the development and testing of therapeutics to treat COVID-19.

From data to drugs - a brief introduction to AI in drug discovery

Oct 16th 2019

The road to an approved drug is well known to be an arduous journey. The use of artificial intelligence (AI) in the drug discovery process is receiving a lot of attention.

News